Invest now
Coral Laboratories share price
Balanced risk
You have to be logged in to add this to Watchlist.- ₹575.90(2.49%)October 6, 2026 10:39:56 AM IST
- NSE
- BSE
- Vol : 0.43 K (NSE + BSE)Last 20 day avg : 1.36 K
Coral Laboratories is trading 2.49% upper at Rs 575.90 as compared to its last closing price. Coral Laboratories has been trading in the price range of 578.80 & 551.00. Coral Laboratories has given 28.14% in this year & -0.15% in the last 5 days. Coral Laboratories has TTM P/E ratio 11.49 as compared to the sector P/E of 33.86.The company posted a net profit of 5.39 Crores in its last quarter.Listed peers of Coral Laboratories include Sun Pharmaceutical Industries (0.06%), Divi's Laboratories (1.71%), Torrent Pharmaceuticals (0.31%).The Mutual Fund holding in Coral Laboratories was at -% in . The MF holding has - from the last quarter. The FII holding in Coral Laboratories was at 0.23% in 30 Jun 2024. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 06 Oct 2026, 12:49 PM IST
- BetaHigh volatility1.35Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.02The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.36Annual dividends as a percentage of the stock price.
- PEG RatioIndicates undervaluation0.28The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Coral Laboratories Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,783.10 | 0.06 | 4,27,815.34 | 39.21 | 5.67 | 0.81 | 0.47 |
| Divi's Laboratories | 9,370.00 | 1.71 | 2,48,744.05 | 75.00 | 11.74 | 0.40 | 0.03 |
| Torrent Pharmaceuticals | 4,769.95 | 0.31 | 1,81,427.07 | 76.65 | 20.25 | 0.76 | 141.16 |
| Cipla | 1,338.60 | 0.34 | 1,08,139.93 | 27.39 | 3.31 | 0.92 | 1.11 |
| Zydus Lifesciences | 1,145.00 | 0.57 | 1,14,214.19 | 20.53 | 4.11 | 0.09 | 14.22 |
Coral Laboratories Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-09-25 | Others |
| 2026-08-14 | Quarterly Results & A.G.M. |
| 2026-05-30 | Audited Results & Final Dividend |
| 2026-02-13 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
About the company Coral Laboratories
- IndustryBiotechnology & Drugs
- ISININE683E01017
- BSE Code524506
- NSE Code
Coral Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in the business of pharmaceutical formulations. The Company is engaged in the manufacturing of generic - branded, nutraceuticals, over the counter (OTC), and herbal medicines. It offers dosage forms, which include tablets, capsules, liquid orals, injections (liquids and powder), ointment and creams, gels and lotions, and suppositories. Its product categories include nutraceutical, OTC, sterile and non-sterile. Its nutraceutical products include DAX 200, DAX 400 Drops, Zest drops, and Super Zestcal Tablets. Its OTC products include herbal range, skin care, medical devices, and effervescent range. Its sterile products include small volume liquid - injectables, lyophilized range - injectables, eye drops, and eardrops. Its non-sterile antibiotics/antibacterials, antifungals, gastro-intestinal drugs, anti-emetics, and muscle relaxants. The Company also exports its products to various countries.
Coral Laboratories Share Price FAQs
Coral Laboratories is trading at 575.90 as on Tue Oct 06 2026 05:09:56. This is 2.49% upper as compared to its previous closing price of 561.90.
The market capitalization of Coral Laboratories is 205.69 Cr as on Tue Oct 06 2026 05:09:56.
The 52 wk high for Coral Laboratories is 679.00 whereas the 52 wk low is 360.00
Coral Laboratories can be analyzed on the following key metrics -
- TTM P/E: 11.49
- Sector P/E: 33.86
- Dividend Yield: 0.36%
- D/E ratio: -
Coral Laboratories reported a net profit of 16.38 Cr in 2026.
Quick Links
EQUITY QUICK LINKS
Coral Laboratories QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.